Restricted

Sorry! This is a private board. You must be invited by one of the board mods of this board!

Permission Required

CYDY IH eyes only(no reposting on ihub, yahoo)

To request access to this board, contact the board moderator d0lphint0m.

Or return to the homepage

Top 10 Most Recent News Articles

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 83

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 156

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Blink Charging Implements Workforce Reduction to Enhance Growth

Updated Category News Views 146

Strategic Workforce Reduction for Growth As a pioneer in electric vehicle charging infrastructure, Blink Charging Co. (NASDAQ: BLNK) has announced a significant workforce reduction initiative designed to accelerate the company's BlinkForward strategic goals. This decision comes as part of a broader operational cost reduction plan aimed at enhancing efficiency and...

Continue Reading
Transforming Evidence Synthesis: AI Innovations with Turacoz

Updated Category News Views 130

AI Innovations in Evidence Synthesis by Turacoz Group In recent times, Turacoz Group has gained recognition for its cutting-edge contributions in real-world evidence (RWE) and health economics and outcomes research (HEOR). At a notable conference in Europe, the innovative company showcased how artificial intelligence (AI) is driving the future of living systematic reviews...

Continue Reading
Exploring the Growing Success of Exxon Mobil Over Five Years

Updated Category News Views 183

The Growth Story of Exxon Mobil Exxon Mobil (NYSE: XOM) has showcased remarkable performance in the stock market over the past five years. With an impressive annualized return of 16.44%, the company surpassed the overall market by 1.69%. This consistency in growth indicates much about Exxon Mobil's potential for future investors. Impact of Compound Returns Understanding...

Continue Reading
Forecasting the $2.68 Billion Growth of Aircraft Lighting

Updated Category News Views 111

Aircraft Lighting Market Growth: A Bright Future Ahead The Aircraft Lighting market is set to experience significant expansion, projected to rise from USD 1.98 billion in 2024 to USD 2.68 billion by 2029, marking a remarkable compound annual growth rate (CAGR) of 6.2%. This growth is propelled by several factors including the ever-increasing demand for air travel,...

Continue Reading
IM Cannabis Corp Welcomes Oz Adler to Its Board of Directors

Updated Category News Views 100

IM Cannabis Corp Strengthens Board with Oz Adler's Expertise IM Cannabis Corp. (NASDAQ: IMCC) is thrilled to announce Mr. Oz Adler's recent appointment to its board of directors. This significant development positions IMC for robust strategic growth in the rapidly evolving cannabis industry. The Insights of Oz Adler Bringing a wealth of knowledge and experience, Mr. Adler...

Continue Reading